155
Views
22
CrossRef citations to date
0
Altmetric
Research Article

Stability and Local Toxicity Evaluation of a Liposomal Prilocaine Formulation

, , , , , , & show all
Pages 329-339 | Published online: 09 Dec 2008

References

  • D. R. Araújo, C.M.S. Cereda, G. B. Brunetto, L. M. A Pinto, M. H. A Santana, and E. de Paula. (2004). Encapsulation of mepivacaine prolongs the analgesia provided by sciatic nerve blockade in mice. Can Anesth 51:566–572.
  • T. Asakawa, and S. Matsushita. (1980). Coloring conditions of thiobarbituric acid test for detecting lipid hydroperoxides. Lipids 15:137–140.
  • I. A. Ball. (1999). Allergic reactions to lignocaine. Br Dent 186:224–226.
  • H. G. Barth, and R. B. Flippen. (1995). Particle size analysis. Anal Chem 67:257–272.
  • J. G. Boogaerts, A. Declercq, N. D. Lafont, H. Benameur, E. M. Akodad, J. C. Dupont, and F. J. Legros. (1993a). Toxicity of bupivaciane encapsulated into lipossomes and injected intravenously: comparison of pain solutions. Anesth Analg 76:553–555.
  • J. G. Boogaerts, N. D. Lafont, H. Luo, and F. J. Legros. (1993b). Plasma concentration of bupivacaine after brachial plexus administration of liposome associated and pain solutions to rabbits. Can Anesth 40:1201–1204.
  • J. G. Boogaerts, N. D. Lafont, A. G. Declercq, C. L. Hongwen, E. T. Gravet, J. A. Bianchi, and F. J. Legros. (1994). Epidural administration of liposome-associated bupivacaine for the management of postsurgical pain: a first study. Clin Anesth 6:315–320.
  • M. M. Campos, and J. B. Calixto. (1995). Involvement of B1 and B2 receptors in braykinin-induced rat paw oedema. Br J Pharmacol 114:1005–1013.
  • C. M. S. Cereda, D. R. Araújo, G. B. Brunetto, and E. de Paula. (2004). Liposomal prilocaine: preparation, characterization and in vivo evaluation. J Pharm Pharmaceut Sci 7:235–240.
  • C. M. S. Cereda, G. B. Brunetto, D. R. Araujo, and E. de Paula. (2006). Liposomal formulations of prilocaine, lidocaine, and mepivacaine prolong analgesic duration. Can J Anesth 53:1092–1097.
  • R. S. Cotran, V. Kumar, and C. Collins. (1999). W. B. Saunders Company, Philadelphia. Robbins Pathologic Basis of Disease
  • M. Dathe, K. Gast, D. Zirwer, H. Welfle, and B. Mehlis. (1990). Insulin aggregation in solution. Int J Pept Protein Res 36:344–349.
  • S. P. Duhgaonkar, S. K. Tandan, A. S. Bhat, S. H. Jadhav, and D. Kumar. (2006). Synergistic anti-inflammatory interaction between meloxicam and aminoguanidine hydrochloride in carrageenan-induced acute inflammation in rats. Life Sci 78:1044–1048.
  • E. S. Fernandes, G. F. Passos, M. M. Campos, J. G. V. C. Araújo, J. L. Pesquero, M. C. Avellar, M. M. Teixeira, and J. B. Calixto. (2003). Mechanisms underlying the modulatory action of platelet activating factor (PAF) on the upregulation of Kinin B1 receptors in the rat paw. Br J Pharmacol 139:973–981.
  • G. J. Grant, Y. Barenholz, B. Piskoun, M. Bansinath, H. Turndorf, and E. M. Bolotin. (2001). DRV liposomal bupivacaine: preparation, characterization, and in vivo evaluation in mice. Pharm Res 18:336–343.
  • G. J. Grant, Y. Barenholz, E. M. Bolotin, M. Bansinath, H. Turndorf, B. Piskoun, and E. M. Davidson. (2004). A novel liposomal bupivacaine formulation to produce ultralong-acting analgesia. Anesthesiology 101:133–137.
  • G. J. Grant, J. Lax, L. Susser, M. Zakowski, T. E. Weissman, and H. Tundorf. (1997). Wound infiltration with liposomal bupivacaine prolongs analgesia in rats. Acta Anaesthesiol Scand 41:204–207.
  • G. J. Grant, and M. Bansinath. (2001). Liposomal delivery systems for local anesthetics. Reg Anesth Pain Med 26:61–63.
  • M. Grit, and D. J. A. Crommelin. (1993). Chemical stability of liposomes: implications for their physical stability. Chem Phys Lipids 64:3–18.
  • G. M. Hanna. (2000). 1H-NMR studies of drugs with chiral solvating agent: the direct enantiomeric purity determination of the chiral anesthetic, prilocaine. Enantiomer 5:303–312.
  • I. Hayashi, K. Ishihara, Y. Kumagai, and M. Majima. (2001). Proinflamatory characteristics of a nonpeptide bradykinin mimic, FR190997, in vivo. Br J Pharmacol 133:1296–1306.
  • D. Lichtenberg, and Y. Barenholz. (1988). Liposomes: preparation, characterization, and preservation. Meth Biochem Anal 33:337–462.
  • J.-M. Malinovsky, D. Benhamou, M. Alafandy, J.-M. Mussini, C. Coussaert, G. Couarraze, M. Pinaud, and F. J. Legros. (1997). Neurotoxicological assessment after intracisternal injection of liposomal bupivacaine in rabbits. Anesth Analg 85:1331–1336.
  • T Mashimo, I. Ushida, M. Pack, A. Shibata, S. Nishimura, Y. Inagaki, and Y. Yoshiya. (1992). Prolongation of canine epidural anesthesia by liposome encapsulation of lidocaine. Anesth Analg 74:827–834.
  • M. R. McCall, and B. Frei. (1999). Can antioxidant vitamins materially reduce oxidative damage in humans?. Free Radic Biol Med 26:1034–1053.
  • H. A. McLure, and A. P. Rubin. (2005). Review of local anaesthetic agents. Minerva Anestesiol 71:59–74.
  • The Merck Index. (1996). Merck & Co. Inc., New Jersey.
  • F. Nantel, D. Denis, R. Gordon, A. Northey, M. Cirino, K. M. Metters, and C. C. Chan. (1999). Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation. Br Pharmacol 128:853–859.
  • R. C. C. New. (1990). Liposomes—A Pratical Aproach. Oxford University Press, New York.
  • H. Ohkawa, N. Ohishi, and K. Yagi. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358.
  • I Posadas, M. Bucci, F. Roviezzo, A. Rossi, L. Parente, L. Sautebin, and G. Cirino. (2004). Carrageenan-induced mouse paw oedema is biphasic, age-weight dependent, and displays differential nitric oxide cyclooxygenase-2 expression. Br Pharmacol 142:331–338.
  • G. Shipper, F. B. Teixeira, R. R. Arnold, and M. Trope. (2005). Periapical inflammation after coronal microbial inoculation of dog roots filled with gutta-percha or resilon. J Endod 31:91–96.
  • A. Taddio, H. K. Soin, S. Schuh, G. Koren, and D. Scolnik. (2005). Liposomal lidocaine to improve procedural success rates and reduce procedural pain among children: a randomized controlled trial. CMAJ 172:1691–1695.
  • V. P. Torchilin. (2005). Recent advances with liposomes as pharmaceutical carriers. Nat Rev 4:145–160.
  • G. J. Tortora, B. R. Funke, and C. L. Case. (2002). Microbiology — An IntroductionBenjamin Cummings, San Francisco.
  • USDHHS. (1987). Guidelines on validation of the Limulus Amebocyte Lysate test as an end-product endotoxin test for human and animal parenteral drugs, biological products, and medical devices. Washington, DC: US Department of Health and Human Services, Food and Drug Administration.
  • C. A. Winter, E. A. Risley, and G. W. Nuss. (1962). Carrageenan-induced edema in hind paw of the rat as an assay for antiinflammatory drugs. Proc Soc Exp Biol Med 3:544–546.
  • E. Yeşilada, and E. Küpeli. (2007). Clematis vitalba L. aerial part exhibits potent anti-inflammatory, antinociceptive and antipyretic effects. J Ethnopharmacol 110:504–515.
  • H. Y. Yu, S. D. Li, and P. Sun. (2002). Kinetic and dynamic studies of liposomal bupivacaine and bupivacaine solution after subcutaneous injection in rats. J Pharm Pharmacol 54:1221–1227.
  • H. Y. Yu, P. Sun, and W. Y. Hou. (1998). Prolonged local anesthetic effect of bupivacaine liposomes in rats. Int Pharm 176:133–136.
  • J. H. Zar. (1999). Biostatistical Analysis. Prentice Hall, New Jersey.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.